eXoZymes Inc
EXOZ
NASDAQ
Biotechnology
$5.82
USD
-0.18 (-3.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $48.26M
Volume 9.1K
About eXoZymes Inc
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
CEO
Mr. Michael Heltzen
HQ
Monrovia California, CALIFORNIA, US
Founded
2024
Employees
32
Key Metrics
2 metrics our research team weighs before forming a view on EXOZ.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
ROE (TTM)
-633.0%
—
Free Cash Flow (TTM)
$-7.09M
—
Financial Snapshot
Revenue
$0
— YoY
Gross Margin
—
— YoY
Net Income
$-9.67M
— YoY
Operating Cash Flow
$-6.89M
— YoY
Key Statistics
Open
$5.89
Previous Close
$6.00
Day Range
$5.82 - $6.49
52 Week Range
$4.35 - $18.40
Volume
9.1K
Average Volume (10 Days)
0
Dividend Yield
—
Valuation Measurement
Market Cap
$48.26M
P/E Ratio (TTM)
—
Price / Book
31.58
Financial Highlights
Return on Assets
-240.7%
Return on Equity
-633.0%
Revenue (TTM)
$0
Net Income (TTM)
$-9.67M
Diluted EPS (TTM)
-$1.15
Total Cash (MRQ)
$1.44M
Levered FCF (TTM)
$-7.09M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 09